Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
Practice Resources & Guidelines
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
The Future of IBD Therapy: Expert Perspectives on Biosimilars
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Medical Therapy
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI; Ross M. Maltz, MD
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Ross M. Maltz, MD
- Melissa Kirkpatrick, PharmD, BCACP
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Medical Therapy
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Millie D. Long, MD, MPH
- Millie D. Long, MD, MPH
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Medical Therapy
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc; Siddharth Singh, MD
- Ryan W. Stidham, MD, MSc
- Siddharth Singh, MD